The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The role of plasma GFAP as a biomarker for glioblastoma.
H. Husain
No relevant relationships to disclose
W. Savage
No relevant relationships to disclose
A. Everett
No relevant relationships to disclose
X. Ye
No relevant relationships to disclose
C. Blair
No relevant relationships to disclose
K. E. Romans
No relevant relationships to disclose
C. Bettegowda
No relevant relationships to disclose
P. Burger
No relevant relationships to disclose
S. A. Grossman
No relevant relationships to disclose
M. Holdhoff
No relevant relationships to disclose